Abstract:In the advanced stages of cancers like melanoma, some of the malignant cells leave the primary tumor and infiltrate the neighboring lymph nodes (LNs). The interaction between secondary cancer and the immune response in the lymph node represents a complex process that needs to be fully understood in order to develop more effective immunotherapeutic strategies. In this process, antigen-presenting cells (APCs) approach the tumor and initiate the adaptive immune response for the corresponding antigen. They stimulate the naive CD4+ and CD8+ T lymphocytes which subsequently generate a population of helper and effector cells. On one hand, immune cells can eliminate tumor cells using cell-cell contact and by secreting apoptosis inducing cytokines. They are also able to induce their dormancy. On the other hand, the tumor cells are able to escape the immune surveillance using their immunosuppressive abilities. To study the interplay between tumor progression and the immune response, we develop two new models describing the interaction between cancer and immune cells in the lymph node. The first model consists of partial differential equations (PDEs) describing the populations of the different types of cells. The second one is a hybrid discrete-continuous model integrating the mechanical and biochemical mechanisms that define the tumor-immune interplay in the lymph node. We use the continuous model to determine the conditions of the regimes of tumor-immune interaction in the lymph node. While we use the hybrid model to elucidate the mechanisms that contribute to the development of each regime at the cellular and tissue levels. We study the dynamics of tumor growth in the absence of immune cells. Then, we consider the immune response and we quantify the effects of immunosuppression and local EGF concentration on the fate of the tumor. Numerical simulations of the two models show the existence of three possible outcomes of the tumor-immune interactions in the lymph node that coincide with the main phases of the immunoediting process: tumor elimination, equilibrium, and tumor evasion. Both models predict that the administration of EGF can promote the elimination of the secondary tumor by PD-1/PD-L1 blockade.

Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment

Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis

How Modulation of the Tumor Microenvironment Drives Cancer Immune Escape Dynamics

Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation

A mathematical model of systemic inhibition of angiogenesis in metastatic development

Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling

A Mathematical Framework for Modelling the Metastatic Spread of Cancer

Characterization of Metastatic Tumor Formation by the Colony Size Distribution

Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade

The evolution of tumor metastases during clonal expansion

Abstract IA013: Stromal and immune plasticity shape the metastatic microenvironment

Homeostatic competition drives tumor growth and metastasis nucleation

A multiscale model of immune surveillance in micrometastases: towards cancer patient digital twins

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment

A mathematical model of tumor self-seeding reveals secondary metastatic deposits as drivers of primary tumor growth

Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration

In Vitro and In Vivo Systems to Study Tumor Dormancy and the Transition to Overt Metastases Induced by the Fibrotic Milieu

Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth

Cancer progression and the invisible phase of metastatic colonization

Bifurcation Analyses and Hormetic Effects of a Discrete-Time Tumor Model

An evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation